Skip to content

Cerba Path

Active
Public limited companyfounded 200422 yrs activeHumaniteitslaan 116, 1070 Anderlecht, BelgiumKBO/BCE: BE 0865.879.606
Summary

Cerba Path has been active since 2004 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €4.1m and a net result of -€207,194. Equity remains stable across the filed fiscal years (±1.1% per year). The computed 12-month bankruptcy probability is 0.9% (low).

Risk analysisWatch ReportCompare
Cerba PathActiveChecked score 67/100
Risk analysis ReportCompare

Overview

Activity
General medical practice
NACE 86210NACE 86901Medical imaging and medical laboratories NACE 86910
1 site
Size
€5.6mtotal assets 2024
Staff
26.9 FTE
Equity
€4.1m
Loss
-€207,194
Financial health
67 Healthy Checked score 2024
Bankruptcy chance 12 m
0.9%
Structure
Parent
CERBA HEALTHCARE BELGIUM · 100%
Holdings
1
Accounts 1 d early0 of 22 deeds read
Why 67- Liquidity: current ratio 2.11- Figures for FY 2024 (filed 05-08-2025)+ Sector Human health activities (NACE 86)+ Equity €4.1m (73.5% of total assets)Show the evidence

Checked score

Score 2024
67 / 100
Healthy
Probability in this band: 0.55% to 1.5%
Better than 39% of its sector peers (NACE 86, small)
Performance against the sector, not lower risk
Every signal that weighs is under Signals.
Financial strength · tick = 2023
Strong
Solvency 99+2
equity 73.5% of total assets
Liquidity 82+1
short-term debt 24.2%
Profitability 53-20
return on assets -3.7%
Bankruptcy probability, 12 months
0.9% Low
0%0.5%1.5%4%10%≥ 25%

About 9 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (1,074 companies)
Last 24 months 11-2024: 0.2%lowest value 12-2024: 0.2%● 0.0% vs 11-2024lowest value 01-2025: 0.2%● 0.0% vs 12-2024lowest value 02-2025: 0.2%● 0.0% vs 01-2025lowest value 03-2025: 0.2%▲ +12.0% vs 02-2025 04-2025: 0.2%▲ +9.0% vs 03-2025 05-2025: 0.2%▲ +3.1% vs 04-2025 06-2025: 0.2%▲ +2.5% vs 05-2025 07-2025: 0.2%▲ +21.1% vs 06-2025 08-2025: 0.4%▲ +76.5% vs 07-2025 09-2025: 0.2%▼ -50.9% vs 08-2025 10-2025: 0.2%● 0.0% vs 09-2025 11-2025: 0.2%● 0.0% vs 10-2025 12-2025: 0.2%● 0.0% vs 11-2025 01-2026: 0.2%● 0.0% vs 12-2025 02-2026: 0.2%● 0.0% vs 01-2026 03-2026: 0.2%▲ +12.1% vs 02-2026 04-2026: 0.3%▲ +8.3% vs 03-2026 05-2026: 0.3%▲ +2.7% vs 04-2026 06-2026: 0.3%▲ +2.6% vs 05-2026 07-2026: 0.3%▲ +1.8% vs 06-2026 08-2026: 0.4%▲ +58.4% vs 07-2026 09-2026: 0.6%▲ +26.2% vs 08-2026 10-2026: 0.9%▲ +58.8% vs 09-2026highest value
  • Liquidity: current ratio 2.11 raises the probability
  • Figures for FY 2024 (filed 05-08-2025) raises the probability
  • Sector Human health activities (NACE 86) lowers the probability
  • Equity €4.1m (73.5% of total assets) lowers the probability
Credit up to €270,000 at 30 days acceptable
Liquidity ample (current ratio 2.11 against 1.87 in 2023; short-term debt: 24.2% of total assets), and 26.5% of the assets are financed with debt.
How it is calculated

The band comes from the bankruptcy probability on a scale of 0 to 100: every 10 points more double the odds of getting through the year without bankruptcy.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Place inside the band: half the bankruptcy probability, half how the company does against its sector peers (NACE 86, small). Better than this share of them on solvency 51%, liquidity 77%, profitability 11%, growth against the median 15%. That is performance, not lower risk; the band itself always comes from the probability.

Bankruptcy probability: model pd-v3.202610021621, computed on 06-10-2026. The model learns from Belgian bankruptcies and reads the registers, the annual accounts and the gazette.

Ceilings: negative or zero equity, a heavy loss, a special KBO legal situation and a missing filing 59 (two missing 44), an ongoing judicial reorganisation or an ending 24. Financial strength does not count in the score.

Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Liquidity: current ratio 2.11
In the bankruptcy model this factor raises the probability.
NBB · annual accounts
raises risk · Figures for FY 2024 (filed 05-08-2025)
In the bankruptcy model this factor raises the probability.
NBB · annual accounts
lowers risk · Sector Human health activities (NACE 86)
In the bankruptcy model this factor lowers the probability.
KBO
lowers risk · Equity €4.1m (73.5% of total assets)
In the bankruptcy model this factor lowers the probability.
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-07-2026, 1 day ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
1 d early
2024
1 d early
2023
20 d early
2022
18 d early
2021
32 d early
2020
4 d early
2019
68 d late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 1 day before the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 13 July (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Position in the running window
07-10-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage
  1. Annual accounts filedfiscal year 2025 · full…
  2. Annual accounts filedfiscal year 2024 · full…
  3. Weakest financial yearnet -€207,194

Key points

  • Caution: From profit to loss in 2024after €181,676 in 2023 -€207,194 View
  • Controlled by CERBA HEALTHCARE BELGIUMultimately: Chrome Topco SA 100% View
  • Positive: Always filed on timeaccounts within the deadline every year 6 years View

By topic

Financials

Fiscal year
2024
Total assets
€5.6m
Loss
-€207,194
Solvency
73.5%
Total assets▼ 6.7%
Net result
20182024
Go to Financials

Timeline

Events
15
Since
2017
Next accounts
by 31-07-2027
  1. 30-07-2026Annual accounts filed
  2. 30-07-2025Annual accounts filed
  3. 31-12-2024Weakest financial year
Go to Timeline

Company details

Sites
1
Legal form
Public limited company
Activity
General medical practiceNACE 86210
Founded
21-06-2004
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure